Allahabad HC: Victim Compensation under POCSO Act Cannot be Withheld For Lack of Injury Report || MP HC: Diverting Goods From Delivery Point is Misappropriation under S.407 IPC || Delhi HC: Bar Associations are Not ‘State’ under Article 12 as They Do Not Perform Public Functions || Delhi HC: Pending Probate Proceedings Do Not Prevent Filing FIR For Alleged Will Forgery || Ker HC: Dismissal For Default Alone Cannot Justify Rejecting Restoration Plea For Lack of Vigilance || SC: Disclosure Statements Alone Cannot Secure Conviction Without a Complete Chain of Evidence || Supreme Court Orders Reporting of Student Suicides and Bans Denial of Classes or Exams || SC: Govt Can Exclude Overqualified Candidates From Posts Requiring Lower Qualifications || SC: Contracts to Hire Global Speakers For Media Summits are Not Taxable as Event Management Services || SC: Mandatory Injunction Suit Alone is Not Maintainable When Plaintiff’s Title is Disputed

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :